Medical Condition News

RSS

Scientists develop new drug for life-threatening lung disease treatment

Researchers are developing a new drug to treat life-threatening lung damage and breathing problems in people with severe infections like pneumonia, those undergoing certain cancer treatments and premature infants with underdeveloped, injury prone lungs.

20 Apr 2016

Study shows pulmonary alveolar proteinosis can be cured by single transfer of monocytes

Researchers from VIB-UGent reveal that adult circulating monocytes that get access to the macrophage niche in the liver or the lung can acquire identical tissue-specific macrophage functions and self-maintenance capacities as macrophages of embryonic origin.

20 Apr 2016

New clinical study to evaluate inexpensive drug to prevent type 1 diabetes

A clinical study evaluating a new hypothesis that an inexpensive drug with a simple treatment regimen can prevent type 1 diabetes will be launched in Dundee tomorrow.

20 Apr 2016

Study shows beneficial effect of hNSC transplantation for TBI

Traumatic brain injury (TBI) is a major cause of mortality and morbidity, often causing lifelong disability for those who survive. Treatment is limited to supportive care, but stem cell therapy has received recent attention as a way to promote recovery for injuries to the central nervous system (CNS). In this study, researchers transplanted human neural stem cells (hNSCs) into the brains of mice modeled with TBI to investigate whether the hosts' immune systems and the stem cells acting in concert would enhance repair.

20 Apr 2016

Immunotherapy drug pembrolizumab shrinks tumors in patients with Merkel cell carcinoma

In a clinical trial of the immunotherapy drug pembrolizumab, half of 25 patients with a rare type of virus-linked skin cancer called Merkel cell carcinoma experienced substantial tumor shrinkage lasting nearly three times as long, on average, than with conventional chemotherapy.

20 Apr 2016

Nivolumab drug shows survival benefit in phase III trial of patients with head and neck cancer

The immunotherapy drug nivolumab has become the first to show a survival benefit in head and neck cancer, after a major international trial found that it was more effective than standard chemotherapy.

20 Apr 2016

FDA expands campaign to educate rural, white male teens about dangers of smokeless tobacco use

The U.S. Food and Drug Administration announced today it is expanding its award-winning "The Real Cost" campaign to educate rural, white male teenagers about the negative health consequences associated with smokeless tobacco use. For the first time, messages on the dangers of smokeless tobacco use – including nicotine addiction, gum disease, tooth loss, and multiple kinds of cancer – are being highlighted through the placement of advertisements in 35 U.S. markets specifically selected to reach the campaign's target audience.

20 Apr 2016

Almost half of all long-stay nursing home residents visit ED every year regardless of cognitive status

A new study from the Indiana University Center for Aging Research and the Regenstrief Institute has found that almost half of all long-stay nursing home residents experience at least one transfer to an Emergency Department over the course of a year regardless of their cognitive status. While a high percentage of long-stay nursing home residents were sent to the ED, only about a third of these individuals were subsequently admitted to the hospital.

20 Apr 2016

Researchers evaluate TBI-associated risk factors in older adults

Traumatic brain injury (TBI), a leading cause of death and disability, has become so common in recent times that it has been called a "silent epidemic." And because older adults are more likely to suffer TBI, have worse outcomes, and are less likely to survive their injury than younger adults, older adults are considered a "silent population" within this epidemic.

20 Apr 2016

Herceptin drugs for breast cancer linked with increased risk of congestive heart failure

Breast cancer patients undergoing treatment with trastuzumab-containing regimens should be monitored for heart damage regardless of age. This is among the findings of a new study from the Peter Munk Cardiac Centre, the Institute for Clinical Evaluative Sciences (ICES) and the Ted Rogers Centre for Heart Research, University Health Network.

20 Apr 2016

Aspirin use linked with reduced risk of developing bile duct cancer

A team of current and former Mayo Clinic researchers has discovered that aspirin use is associated with a significantly reduced risk of developing bile duct cancer, also called cholangiocarcinoma. The results are published in Hepatology.

20 Apr 2016

Researchers examine effectiveness of antipsychotic drugs to prevent or treat delirium

In a study published in the Journal of the American Geriatrics Society, researchers examined whether or not antipsychotic drugs, which are sometimes used to prevent or treat delirium, are effective.

20 Apr 2016

Small piece of detoxified E. coli wall makes mice lose natural sweet tooth, study finds

Putting just a tiny piece of the wall of detoxified E. coli into their gut make mice lose their natural sweet tooth, researchers report.

20 Apr 2016

Drexel study provides new insight into future treatment of breathing disorders

Bringing a steady supply of fresh air to the lungs can seem like a simple task, but breathing is a careful orchestration of brain and body.

20 Apr 2016

Researchers reveal possibility for in-body ultrasonic communications with implanted medical devices

Using animal tissue samples--store-bought pork loin and beef liver--researchers from the University of Illinois at Urbana-Champaign have demonstrated the possibility of real-time video-rate data transmission through tissue for in-body ultrasonic communications with implanted medical devices.

19 Apr 2016

Scientists identify underlying cause of immune suppression in people with high level spinal cord injuries

Scientists report in Nature Neuroscience they have identified an underlying cause of dangerous immune suppression in people with high level spinal cord injuries and they propose a possible treatment.

19 Apr 2016

Psilocybin administration reduces reaction to social rejection in associated brain areas

Social ties are vital for mental and physical health. However, psychiatric patients in particular frequently encounter social exclusion and rejection. Furthermore, psychiatric patients often react more strongly to social rejection than healthy persons and this can have negative consequences for the development and treatment of psychiatric disorders.

19 Apr 2016

Health systems rely on design thinking for management and innovation

Current health system practices are not sufficient to address growing rates of obesity and diabetes, health and economic disparities and cost control. "A Design Thinking Framework for Healthcare Management and Innovation" argues that addressing these complex challenges will require leaders that can think, and act, more like designers.

19 Apr 2016

Tecnalia's transparent bioadjesive gel could treat diabetic foot ulcers

Tecnalia's Pharmaceutical Development laboratory conducts the selection of the candidate polymers and topical antiseptics necessary to obtain a stable, safe and effective formula in the form of a transparent bioadjesive gel specific for the treatment of diabetic foot ulcers.

19 Apr 2016

Researchers find mechanism behind pancreatic cancer cells' resistance to certain drugs

Pancreatic cancer is on track to become the second leading cause of cancer-related deaths by 2020. These statistics are due, in part, to pancreatic cancer's resistance to most targeted cancer therapies. Working with pancreatic cancer cells, researchers have now found a mechanism that could be responsible for the cancer's resistance to at least one targeted approach.

19 Apr 2016

Medical Condition News

Scientists develop new drug for life-threatening lung disease treatment

Study shows pulmonary alveolar proteinosis can be cured by single transfer of monocytes

New clinical study to evaluate inexpensive drug to prevent type 1 diabetes

Study shows beneficial effect of hNSC transplantation for TBI

Immunotherapy drug pembrolizumab shrinks tumors in patients with Merkel cell carcinoma

Nivolumab drug shows survival benefit in phase III trial of patients with head and neck cancer

FDA expands campaign to educate rural, white male teens about dangers of smokeless tobacco use

Almost half of all long-stay nursing home residents visit ED every year regardless of cognitive status

Researchers evaluate TBI-associated risk factors in older adults

Herceptin drugs for breast cancer linked with increased risk of congestive heart failure

Aspirin use linked with reduced risk of developing bile duct cancer

Researchers examine effectiveness of antipsychotic drugs to prevent or treat delirium

Small piece of detoxified E. coli wall makes mice lose natural sweet tooth, study finds

Drexel study provides new insight into future treatment of breathing disorders

Researchers reveal possibility for in-body ultrasonic communications with implanted medical devices

Scientists identify underlying cause of immune suppression in people with high level spinal cord injuries

Psilocybin administration reduces reaction to social rejection in associated brain areas

Health systems rely on design thinking for management and innovation

Tecnalia's transparent bioadjesive gel could treat diabetic foot ulcers

Researchers find mechanism behind pancreatic cancer cells' resistance to certain drugs

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Latest News